A Revised Optical Coherence Tomography-Derived Calcium Score to Predict Stent Underexpansion in Severely Calcified Lesions
- PMID: 40074518
- DOI: 10.1016/j.jcin.2024.12.001
A Revised Optical Coherence Tomography-Derived Calcium Score to Predict Stent Underexpansion in Severely Calcified Lesions
Abstract
Background: Severe calcification is the morphology most strongly associated with stent underexpansion.
Objectives: The aim of this study was to revise an optical coherence tomography (OCT)-derived calcium score to predict stent underexpansion in severely calcified lesions (angle >270°) using a point-based system.
Methods: A retrospective observational study was conducted in which 250 de novo lesions undergoing OCT-guided stenting, with angiographically visible calcium and optical coherence tomographic maximum superficial calcium angle >270°, not subjected to atherectomy or specialty balloon treatment before stent implantation, were randomly divided into derivation (n = 167) and validation (n = 83) cohorts. The endpoint was stent expansion (minimum stent area/average of reference luminal area) at the maximum calcium deposition site, and stent expansion <70% was considered underexpansion.
Results: Stent underexpansion was present in 19.6% of lesions (49 of 250). In the multivariable linear regression model, the morphologic characteristics associated with stent expansion in the derivation cohort were: 1) calcium >270° with a length longer than 3 mm (regression coefficient = -10.3; 95% CI: -17.8 to -2.8; P = 0.007); 2) calcium angle of 360° (regression coefficient = -15.5; 95% CI: -25.2 to -5.8; P = 0.002); and 3) minimum calcium thickness >0.30 mm (regression coefficient = -12.4; 95% CI: -19.1 to -5.6; P = 0.0004). In the validation cohort, the calcium score (range: 0-3) was significantly correlated with stent expansion (regression coefficient = -9.1; 95% CI: -12.6 to -6.1; P < 0.0001).
Conclusions: This revised OCT-derived calcium score can serve as a reliable tool for identifying severely calcified lesions at risk for stent underexpansion.
Keywords: optical coherence tomography; percutaneous coronary intervention; severe calcified plaque; stent(s).
Copyright © 2025 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures Dr Matsumura is a consultant to Boston Scientific and Terumo. Dr Shlofmitz is a consultant to Abbott Vascular, ACIST Medical Systems, Boston Scientific, Opsens Medical, Philips, Shockwave Medical, and Terumo. Dr Khalique has received speaker fees from Edwards Lifesciences. Dr Cohen has received research grant support from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, Phillips, and CathWorks; and has received consulting income from Abbott, Boston Scientific, Edwards Lifesciences, and Medtronic. Dr Mintz has received honoraria from Boston Scientific, Philips, Abbott, SpectraWAVE, and Gentuity. Dr Shlofmitz is a speaker for Shockwave Medical. Dr Jeremias has received institutional grants and consulting fees from Abbott Vascular and Philips/Volcano; and has received consulting fees from ACIST Medical Systems and Boston Scientific. Dr Ali has received institutional research grants for Columbia University from Abbott and Cardiovascular Systems; and serves as a consultant for Abbott, Abiomed, AstraZeneca, and Shockwave Medical. Dr Maehara is a consultant for Boston Scientific, Philips, and SpectraWAVE; and has received speaker honoraria from Nipro. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
